Stifel Nicolaus Cuts OrthoPediatrics (NASDAQ:KIDS) Price Target to $32.00

OrthoPediatrics (NASDAQ:KIDS) had its price objective decreased by Stifel Nicolaus from $40.00 to $32.00 in a research note released on Wednesday morning,Benzinga reports. Stifel Nicolaus currently has a buy rating on the stock.

Other equities analysts have also recently issued research reports about the stock. Truist Financial reduced their price target on shares of OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating on the stock in a research report on Wednesday, December 18th. Needham & Company LLC reiterated a “buy” rating and set a $42.00 price target on shares of OrthoPediatrics in a research report on Wednesday.

OrthoPediatrics Price Performance

Shares of OrthoPediatrics stock opened at $25.61 on Wednesday. The company’s fifty day simple moving average is $24.39 and its two-hundred day simple moving average is $25.94. The firm has a market cap of $620.17 million, a PE ratio of -20.82 and a beta of 1.14. The company has a quick ratio of 3.68, a current ratio of 7.17 and a debt-to-equity ratio of 0.19. OrthoPediatrics has a 12-month low of $21.02 and a 12-month high of $35.99.

OrthoPediatrics (NASDAQ:KIDS) last announced its quarterly earnings results on Tuesday, March 4th. The company reported ($0.29) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.33) by $0.04. OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.78%. The company had revenue of $52.67 million for the quarter, compared to analysts’ expectations of $51.16 million. During the same quarter in the previous year, the company earned ($0.23) earnings per share. As a group, equities analysts expect that OrthoPediatrics will post -0.93 EPS for the current year.

Institutional Investors Weigh In On OrthoPediatrics

A number of hedge funds and other institutional investors have recently bought and sold shares of KIDS. Creative Planning grew its holdings in OrthoPediatrics by 15.4% in the third quarter. Creative Planning now owns 10,130 shares of the company’s stock worth $275,000 after purchasing an additional 1,353 shares during the period. International Assets Investment Management LLC grew its holdings in OrthoPediatrics by 2,610.8% in the third quarter. International Assets Investment Management LLC now owns 1,003 shares of the company’s stock worth $27,000 after purchasing an additional 966 shares during the period. Mutual of America Capital Management LLC grew its holdings in OrthoPediatrics by 195.1% in the third quarter. Mutual of America Capital Management LLC now owns 107,609 shares of the company’s stock worth $2,917,000 after purchasing an additional 71,146 shares during the period. Quest Partners LLC lifted its stake in shares of OrthoPediatrics by 924.4% in the third quarter. Quest Partners LLC now owns 11,986 shares of the company’s stock worth $325,000 after buying an additional 10,816 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of OrthoPediatrics in the third quarter worth approximately $295,000. Hedge funds and other institutional investors own 69.05% of the company’s stock.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.